Biogena Group Invest AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '25 Jul 31, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Revenue	367.88	368.41	166.06	251.11	331.06	329.3
Revenue Growth (YoY)	180.32%	121.86%	-33.87%	-24.15%	0.53%	-
Gross Profit	367.88	368.41	166.06	251.11	331.06	329.3
Other Operating Expenses	-176.36	-172.61	-162.62	157.95	406.9	-289.41
Total Operating Expenses	-176.36	-172.61	-162.62	157.95	406.9	-289.41
Operating Income	191.7	195.63	3.43	93.16	-75.85	39.9
Total Non-Operating Income (Expense)	138.14	138.14	172.47	208.56	892.54	111.05
Pretax Income	329.85	333.77	175.9	301.72	816.69	150.95
Provision for Income Taxes	-21.3	-3.5	-3.5	3.52	81.43	-34.29
Net Income	351.14	337.27	179.4	298.19	735.26	185.24
Net Income to Common	305.05	330.27	172.4	298.19	735.26	116.65
Net Income Growth	73.28%	91.57%	-42.18%	-59.44%	530.29%	-
Shares Outstanding (Basic)	4	4	4	4	4	-
Shares Outstanding (Diluted)	4	4	4	4	4	-
EPS (Basic)	76.45	82.77	43.21	74.73	184.28	-
EPS (Diluted)	76.45	82.77	43.21	74.73	184.28	-
EPS Growth	73.28%	91.57%	-42.18%	-59.44%	-	-
Free Cash Flow	-	-0.01	0.03	0.41	-0.29	0
Free Cash Flow Growth	-	-	-93.84%	-	-	-
Free Cash Flow Per Share	-	-0.00	0.01	0.10	-0.07	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	52.11%	53.10%	2.07%	37.10%	-22.91%	12.12%
Profit Margin	95.45%	91.55%	108.03%	118.75%	222.09%	56.25%
FCF Margin	-	-0.00%	0.02%	0.16%	-0.09%	0.00%
EBITDA	191.7	195.63	3.43	93.16	-75.85	39.9
EBIT	191.7	195.63	3.43	93.16	-75.85	39.9
EBIT Margin	52.11%	53.10%	2.07%	37.10%	-22.91%	12.12%
Effective Tax Rate	-6.46%	-1.05%	-1.99%	1.17%	9.97%	-22.72%